The expression of KLF9 and KLF13 in tumor-associated immune cells and tumor stroma, coupled with the known biology of these proteins in circulating immune cells, makes a strong case for focusing on the functions of these two KLFs in the tumor microenvironment of solid tumors and blood cancers. Here, KLF9 is linked to hematopoietic and lymphoid system neoplasm.